Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harry R. Weller currently holds 3,151,611 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry R. Weller has been a net buyer of TCON stock. They have purchased $162.5M and sold $67.8M worth of shares.
Harry R. Weller's most recent insider trade was on Oct 31, 2016, when they sold 623,210 shares at $0.00 per share.
Harry R. Weller serves as Executive at Tracon Pharmaceuticals, Inc. (TCON). They have executed 117 insider transactions totaling $230.3M over their tenure at the company.
Harry R. Weller holds the position of Executive at Tracon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Harry R. Weller has shown a buying trading pattern, with $162.5M in total purchases and $67.8M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Harry R. Weller was on Mar 18, 2016, when they purchased $25.0M worth of TSRO shares. This transaction involved 710,429 shares at $35.19 per share.
Harry R. Weller currently owns 3,151,611 shares of Tracon Pharmaceuticals, Inc. (TCON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harry R. Weller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harry R. Weller has 117 Form 4 filings on record as an insider at Tracon Pharmaceuticals, Inc..
Set alerts for Harry R. Weller and 40,000+ other insiders.